BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
CLSA upgrades IPCA Labs to buy
Company has strong earnings trajectory. US business of company will ramp up. Expect US market revenue to be strong. Target Rs 863.